From Seattle, at the 9th Annual Conference on Retroviruses and Opportunistic Infections
Just a few days after the National Institutes of Health announced it was canceling a large AIDS-vaccine trial, researchers at this meeting announced preliminary results from a new vaccine that appears safe. Although the vaccine probably won’t keep people from getting infected, it could help them fight the infection.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.